AbbVie sues drug cost savings company over alleged fraudulent use of patient assistance program
AbbVie sued drug cost savings company Payer Matrix in federal court last week, alleging that the company is operating a “fraudulent and deceptive scheme” and taking advantage of AbbVie’s patient assistance program.
AbbVie alleged that Payer Matrix has been enrolling insured patients into its myAbbVie Assist Patient Assistance Program (PAP) who aren’t truly eligible, according to a complaint filed in the US District Court for the Northern District of Illinois Eastern Division. The pharma giant claimed the company knows that the program is only for uninsured or underinsured patients but enrolls its clients anyway, including those who should be getting medicine through employer insurance plans.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters